The therapeutic options for patients with noninvasive or invasive breast cancer are complex
and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include …

Neoadjuvant chemotherapy (NAC) involves administration of chemotherapeutic agents to
patients with newly diagnosed breast cancer prior to definitive surgical treatment …

PURPOSE: To identify a cohort of women treated with neoadjuvant chemotherapy and
mastectomy for whom postmastectomy radiation therapy (PMRT) may be omitted according …

OBJECTIVE: To determine indications for the use of postmastectomy radiotherapy (PMRT)
for patients with invasive breast cancer with involved axil-lary lymph nodes or locally …

Purpose To use pathologic indicators to determine which patients benefit from
postmastectomy radiation therapy (PMRT) for breast cancer after neoadjuvant …

The optimal surgical management of locally advanced breast cancer (LABC) remains
undefined. The aim of the study was to obtain long‐term results of oncoplastic surgery in …

Purpose To describe the clinical outcomes of patients with locally advanced breast cancer
(LABC) receiving neoadjuvant chemotherapy and preoperative radiotherapy, followed by …

To determine easy-to-use predictors of overall survival (OS), locoregional recurrence (LRR),
and distant metastasis (DM) in breast invasive ductal carcinoma (IDC) patients receiving …

Abstract Purpose of Review Postmastectomy radiation therapy (PMRT) has been shown to
reduce the risk of locoregional recurrences (LRR) and of distant metastases (DM) and to …

Postmastectomy irradiation (PMRT) clearly reduces the risk of localregional failure (LRF) for
patients with invasive breast cancer. For many years, however, it has been controversial …